ВЗАИМОСВЯЗЬ ПОЛИМОРФИЗМА VDR C.IVS7 G>A С ПЕРЕНЕСЁННЫМ COVID-19 И ПОКАЗАТЕЛЯМИ КОСТНОГО МЕТАБОЛИЗМА
- Авторы:Валиева Камола Нуруллаевна
- Дата публикации:November 19, 2026
- Тип:Статья
- DOI: 10.64156/mju.9997 Скопировано
- Том / № Выпуска:Том 1 №6 (2026)
Аннотация
Аннотация: Цель исследования. Оценить роль полиморфизма VDR c.IVS7 G>A (rs1544410) в развитии асептического остеонекроза крупных суставов, а также изучить его связь с минеральной плотностью костной ткани и показателями костного метаболизма у пациентов с учетом перенесённой коронавирусной инфекции COVID-19.
Материалы и методы. В исследование были включены 98 пациентов с асептическим остеонекрозом крупных суставов, проходивших лечение в Республиканском специализированном научно-практическом медицинском центре травматологии и ортопедии (г. Ташкент) в 2020–2025 гг., и 95 условно здоровых лиц контрольной группы. Генотипирование полиморфизма VDR c.IVS7 G>A (rs1544410) проводили методом ПЦР–РФЛП. Проанализированы распределение аллелей и генотипов, минеральная плотность костной ткани позвоночника и бедренной кости, а также уровни кальция, β-C-концевого телопептида коллагена I типа (β-CTX), 25-гидроксивитамина D [25(OH)D] и С-реактивного белка (CRP) в зависимости от генотипа и наличия COVID-19 в анамнезе.
Результаты. У пациентов, перенёсших COVID-19, выявлена ассоциация полиморфизма VDR c.IVS7 G>A (rs1544410) с развитием асептического остеонекроза: носительство минорного A-аллеля сопровождалось повышением риска заболевания, тогда как G-аллель проявлял тенденцию к протективному эффекту. У пациентов без COVID-19 достоверной связи между исследуемым полиморфизмом и заболеванием не установлено. Носители генотипа A/A характеризовались более ранним возрастом манифестации заболевания. Влияние полиморфизма на минеральную плотность костной ткани носило возраст- и полозависимый характер: наиболее выраженное снижение показателей выявлено у женщин старше 50 лет с генотипом A/A. Установлены генотип-зависимые особенности показателей кальциевого обмена и костного ремоделирования, тогда как различия уровней 25(OH)D и CRP между генотипами статистически значимыми не были.
Заключение. Полиморфизм VDR c.IVS7 G>A (rs1544410) ассоциирован с повышенной предрасположенностью к асептическому остеонекрозу у пациентов, перенёсших COVID-19, и оказывает возраст- и полозависимое влияние на минеральную плотность костной ткани и показатели костного ремоделирования. Минорный A-аллель, особенно в составе генотипа A/A, может рассматриваться как потенциальный генетический маркер ранней манифестации заболевания и структурных нарушений костной ткани.
Ключевые слова: асептический некроз; рецептор витамина D; VDR; rs1544410; BsmI; минеральная плотность костной ткани; COVID-19; костное ремоделирование; витамин D; генетический полиморфизм.
Annotatsiya. Tadqiqot maqsadi. VDR c.IVS7 G>A (rs1544410) polimorfizmining yirik bo‘g‘imlar aseptik osteonekrozi rivojlanishidagi rolini baholash hamda uning koronavirus infeksiyasi (COVID-19)ni boshdan kechirgan va boshdan kechirmagan bemorlarda suyak mineral zichligi va suyak metabolizmi ko‘rsatkichlari bilan bog‘liqligini o‘rganish.
Materiallar va usullar. Tadqiqotga 2020–2025-yillarda Respublika ixtisoslashtirilgan travmatologiya va ortopediya ilmiy-amaliy tibbiyot markazida (Toshkent shahri) davolangan yirik bo‘g‘imlar aseptik osteonekrozi bilan kasallangan 98 nafar bemor hamda 95 nafar shartli sog‘lom nazorat guruhi ishtirokchilari kiritildi. VDR c.IVS7 G>A (rs1544410) polimorfizmini genotiplash PZR–RFLP usuli yordamida amalga oshirildi. Allellar va genotiplar taqsimoti, umurtqa pog‘onasi va son suyagining mineral zichligi, shuningdek, kalsiy, β-C-terminal I tip kollagen telopeptidi (β-CTX), 25-gidroksivitamin D [25(OH)D] va C-reaktiv oqsil (CRP) darajalari genotip hamda COVID-19 anamnezi hisobga olingan holda tahlil qilindi.
Natijalar. COVID-19ni boshdan kechirgan bemorlarda VDR c.IVS7 G>A (rs1544410) polimorfizmining aseptik osteonekroz rivojlanishi bilan bog‘liqligi aniqlandi: minor A allelini tashuvchilarda kasallik rivojlanish xavfi yuqoriroq bo‘lgan, G alleli esa himoya qiluvchi ta’sirga moyillikni namoyon etgan. COVID-19ni boshdan kechirmagan bemorlarda mazkur polimorfizm bilan kasallik o‘rtasida ishonchli bog‘liqlik aniqlanmadi. A/A genotipiga ega bemorlarda kasallikning namoyon bo‘lish yoshi ancha erta ekanligi kuzatildi. Polimorfizmning suyak mineral zichligiga ta’siri yosh va jinsga bog‘liq bo‘lib, eng yaqqol pasayish 50 yoshdan katta ayollarda A/A genotipida qayd etildi. Shuningdek, kalsiy almashinuvi va suyak remodelatsiyasi ko‘rsatkichlarida genotipga bog‘liq farqlar aniqlandi, biroq 25(OH)D va CRP darajalari bo‘yicha statistik jihatdan ishonchli tafovutlar kuzatilmadi.
Xulosa. VDR c.IVS7 G>A (rs1544410) polimorfizmi COVID-19ni boshdan kechirgan bemorlarda aseptik osteonekrozga genetik moyillik bilan bog‘liq bo‘lib, suyak mineral zichligi va suyak remodelatsiyasi ko‘rsatkichlariga yosh hamda jinsga bog‘liq ta’sir ko‘rsatadi. Minor A alleli, ayniqsa A/A genotipi tarkibida, kasallikning erta namoyon bo‘lishi va suyak to‘qimasidagi strukturaviy o‘zgarishlarga moyillikning potensial genetik markeri sifatida qaralishi mumkin.
Kalit so‘zlar: aseptik osteonekroz; D vitamini retseptori; VDR; rs1544410; BsmI; suyak mineral zichligi; COVID-19; suyak remodelatsiyasi; D vitamini; genetik polimorfizm.
Background. The vitamin D receptor (VDR) plays a pivotal role in bone metabolism, calcium homeostasis, and immune regulation. The VDR c.IVS7 G>A (rs1544410, BsmI) polymorphism has been associated with variations in bone mineral density (BMD), vitamin D metabolism, and susceptibility to several skeletal and metabolic disorders. However, its contribution to the development of aseptic osteonecrosis, particularly following coronavirus disease (COVID-19), remains poorly understood.
Objective. To evaluate the role of the VDR c.IVS7 G>A (rs1544410) polymorphism in the development of aseptic osteonecrosis and to assess its association with bone metabolism parameters in patients with and without a history of COVID-19.
Materials and Methods. A total of 98 patients with post-COVID aseptic osteonecrosis of major joints treated at the Republican Specialized Scientific and Practical Medical Center of Traumatology and Orthopedics (Tashkent, Uzbekistan) between 2020 and 2025 and 95 apparently healthy controls were enrolled. Genotyping of the VDR c.IVS7 G>A (rs1544410) polymorphism was performed using the PCR–RFLP method. Allele and genotype distributions, bone mineral density, serum calcium, β-C-terminal telopeptide of type I collagen (β-CTX), 25-hydroxyvitamin D [25(OH)D], and C-reactive protein (CRP) concentrations were analyzed according to genotype.
Results. Among patients with a history of COVID-19, the A allele was associated with an increased risk of aseptic osteonecrosis, whereas the G allele demonstrated a protective trend. No significant association was observed in patients without previous COVID-19 infection. Carriers of the A/A genotype developed the disease at a younger age than carriers of the G/G and G/A genotypes. The influence of the VDR polymorphism on bone mineral density was age- and sex-dependent. Reduced BMD associated with the A/A genotype was observed predominantly in women older than 50 years, affecting both the lumbar spine and proximal femur. Genotype-dependent differences were also identified in serum calcium and β-CTX concentrations, suggesting altered bone remodeling, whereas no significant differences in serum 25(OH)D or CRP levels were detected.
Conclusions. The VDR c.IVS7 G>A (rs1544410) polymorphism is associated with susceptibility to aseptic osteonecrosis in patients with a history of COVID-19 and may contribute to age- and sex-dependent alterations in bone metabolism. The A allele, particularly in the homozygous A/A genotype, appears to be associated with earlier disease onset, reduced bone mineral density, and changes in bone remodeling, suggesting that this genetic variant may represent a potential marker of susceptibility to structural bone deterioration in aseptic osteonecrosis.
Keywords: aseptic osteonecrosis; vitamin D receptor; VDR; rs1544410; BsmI; bone mineral density; COVID-19; bone remodeling; vitamin D; genetic polymorphism.
References
- Poon AH, Gong L, Brasch-Andersen C, Litonjua AA, Raby BA, Hamid Q, Laprise C, Weiss ST, Altman RB, Klein TE. Very important pharmacogene summary for VDR. Pharmacogenet Genomics. 2012 Oct;22(10):758-63. doi: 10.1097/FPC.0b013e328354455c.
- González Rojo, P.; Pérez Ramírez, C.; Gálvez Navas, J.M.; Pineda Lancheros, L.E.; Rojo Tolosa, S.; Ramírez Tortosa, M.d.C.; Jiménez Morales, A. Vitamin D-Related Single Nucleotide Polymorphisms as Risk Biomarker of Cardiovascular Disease. Int. J. Mol. Sci. 2022, 23, 8686. https://doi.org/10.3390/ijms23158686
- Shaat N, Katsarou A, Shahida B, Prasad RB, Kristensen K, Planck T. Association between the rs1544410 polymorphism in the vitamin D receptor (VDR) gene and insulin secretion after gestational diabetes mellitus. PLoS One. 2020 May 14;15(5):e0232297. doi: 10.1371/journal.pone.0232297.
- Gholami, A., Montazeri-Najafabady, N., Karimzadeh, I. et al. The effect of BsmI (rs1544410) single nucleotide polymorphism of vitamin D receptor (VDR) on insulin resistance in healthy children and adolescents: a cross-sectional study. BMC Pediatr 24, 54 (2024). https://doi.org/10.1186/s12887-023-04503-2
- Zhao XQ, Wan HY, He SY, Qin HJ, Yu B, Jiang N. Vitamin D Receptor Genetic Polymorphisms Associate With a Decreased Susceptibility to Extremity Osteomyelitis Partly by Inhibiting Macrophage Apoptosis Through Inhibition of Excessive ROS Production via VDR-Bmi1 Signaling. Front Physiol. 2022 Jul 25;13:808272. doi: 10.3389/fphys.2022.808272.
- Yin, Xin MDa; Wang, Huadong MDa; Guo, Jidong MDa; Zhang, Liang MDb; Zhang, Yupeng MDa; Li, Li MDa,*; Hou, Shuxun MDa,*. Association of vitamin D receptor BsmI rs1544410 and ApaI rs7975232 polymorphisms with susceptibility to adolescent idiopathic scoliosis: A systematic review and meta-analysis. Medicine 97(2):p e9627, January 2018. | DOI: 10.1097/MD.0000000000009627
- Thekra A. Al-Kashwan, Abdul Hussein A. Algenabi, Ali M. Omara, Ahmed N. Kaftan, Association of vitamin D receptor gene polymorphisms BsmI (rs 1544410) and TaqI rs (731236) with the type 2 diabetes mellitus in Iraqi Patients from the middle Euphrates region, Meta Gene, Volume 28, 2021, 100854, ISSN 2214-5400, https://doi.org/10.1016/j.mgene.2021.100854
- Sîrbu AC, Bocșan IC, Sabin O, Pop RM, Vesa ȘC, Feketea G, Briciu V, Lupșe M, Buzoianu AD. Exploring the Association of Vitamin D and VDR Polymorphisms with Disease Severity in COVID-19 and Influenza. Biomedicines. 2025 Oct 25;13(11):2617. doi: 10.3390/biomedicines13112617.
- Jawad MU, Haleem AA, Scully SP. In brief: Ficat classification: avascular necrosis of the femoral head. Clin Orthop Relat Res. 2012 Sep;470(9):2636-9. doi: 10.1007/s11999-012-2416-2.
- Matthews AH, Davis DD, Fish MJ, et al. Avascular Necrosis. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537007/
- Nazal, Mark & Parsa, Ali & Martin, Scott. (2019). Mid-term outcomes of arthroscopic-assisted Core decompression of Precollapse osteonecrosis of femoral head—minimum of 5 year follow-up. BMC Musculoskeletal Disorders. 20. 10.1186/s12891-019-2853-0.
- Mydlárová Blaščáková M, Lőrinczová Z, Anderková L, Czerwińska-Ledwig O, Mikulová Ľ, Hrušovská H, Jędrzejkiewicz B, Piotrowska A. Relationship Between Vitamin D Receptor Gene BsmI Polymorphism and 25-Hydroxyvitamin D Total Levels in Slovak Postmenopausal Women with Reduced Bone Mineral Density. Genes (Basel). 2025 Mar 13;16(3):337. doi: 10.3390/genes16030337.
- Gabdulkayum A, Amangeldikyzy S, Khassanova S, Yerezhepov A, Akilzhanov K, Kozhamkulov U, Rakhimova S, Kairov U, Yerezhepov D, Akilzhanova A. The association of VDR gene polymorphisms with serum vitamin D levels and injury predisposition in elite athletes of Kazakhstan. Eur J Appl Physiol. 2025 Oct 13. doi: 10.1007/s00421-025-05976-y.
- Al-Barazenji, T.; Allouch, A.; Al Husaini, N.; Yousef, S.; Ibrahim, W.N.; Al-Haidose, A.; Zayed, H.; Abdallah, A.M. Association Between Vitamin D Receptor BsmI Polymorphism and Low Bone Mineral Density in Postmenopausal Women in the MENA Region. Pathophysiology 2025, 32, 6. https://doi.org/10.3390/pathophysiology32010006
- Schulz N, Dischereit G, Henke L, Lange U, Klemm P. Prevalence and effects of Vitamin D receptor polymorphism on bone mineral density and metabolism in patients with systemic sclerosis: a preliminary study. Clin Exp Med. 2024 Jun 7;24(1):121. doi: 10.1007/s10238-024-01385-1.
- Mondockova V, Kovacova V, Zemanova N, Babikova M, Martiniakova M, Galbavy D, Omelka R. Vitamin D Receptor Gene Polymorphisms Affect Osteoporosis-Related Traits and Response to Antiresorptive Therapy. Genes (Basel). 2023 Jan 11;14(1):193. doi: 10.3390/genes14010193.
- Li Q, Li W, Chen M, Chai Y, Guan L, Chen Y. Association of vitamin D receptor gene polymorphism with the risk of sepsis: A systematic review and meta-analysis. Medicine (Baltimore). 2023 Sep 22;102(38):e35130. doi: 10.1097/MD.0000000000035130.
- .Al-Daghri NM, Guerini FR, Al-Attas OS, Alokail MS, Alkharfy KM, Draz HM, et al. (2014) Vitamin D Receptor Gene Polymorphisms Are Associated with Obesity and Inflammosome Activity. PLoS ONE 9(7): e102141. https://doi.org/10.1371/journal.pone.0102141
- Sumegha Mitra, Meena Desai, M. Ikram Khatkhatay, Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women, Maturitas, Volume 55, Issue 1, 2006, Pages 27-35, ISSN 0378-5122, https://doi.org/10.1016/j.maturitas.2006.01.003.
- Long J, Liu P, Zhang Y, Shen H, Liu Y, Dvornyk V, Deng HW. Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese. J Hum Genet. 2003;48(10):514-519. doi: 10.1007/s10038-003-0068-5.